Coagulation Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
The coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.
Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.
Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market
Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.
According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per ‘Global Burden of Disease Study 2019,’ CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.
A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.
The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand's disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.
Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people—at least 30,000 Canadians—have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.
American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.
Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.
- In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.
- In April 2020, US-based Haemonetics Corporation acquired Enicor, a blood coagulation diagnostic system developer.
- In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.
- In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
- In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
- In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation tests. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.
Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market
Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.
According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per ‘Global Burden of Disease Study 2019,’ CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.
A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.
The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand's disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.
Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people—at least 30,000 Canadians—have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.
American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. COAGULATION MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. COAGULATION MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Market Drivers
5.1.2 Increasing Prevalence of Blood Disorders
5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. COAGULATION MARKET - GLOBAL MARKET ANALYSIS
6.1 Coagulation Market Revenue (US$ million), 2022 – 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030
7. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE INDICATION
7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
7.3.1 Overview
7.3.2 Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
7.4.1 Overview
7.4.2 Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
7.5.1 Overview
7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
7.6.1 Overview
7.6.2 Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
7.7.1 Overview
7.7.2 Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand's Disease
7.8.1 Overview
7.8.2 Von Willebrand's Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY TYPE
8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
8.3.1 Overview
8.3.2 Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
8.4.1 Overview
8.4.2 Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY OFFERING
9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
9.3.1 Overview
9.3.2 Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
9.4.1 Overview
9.4.2 Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Global Coagulation Market, by Treatment
10. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
10.3.1 Overview
10.3.2 Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
10.4.1 Overview
10.4.2 Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
10.5.1 Overview
10.5.2 Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
11.3.1 Overview
11.3.2 Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
12. COAGULATION MARKET - GEOGRAPHICAL ANALYSIS
12.1 North America Coagulation Market, Revenue And Forecast To 2030
12.1.1 Overview
12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.3 North America Coagulation Market, by Disease Indication
12.1.4 North America Coagulation Market, by Type
12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
12.1.5 North America Coagulation Market, by Offering
12.1.5.1 North America Coagulation Market, by Diagnosis
12.1.5.2 North America Coagulation Market, by Treatment
12.1.6 North America Coagulation Market, by Technology
12.1.7 North America Coagulation Market, by End User
12.1.7.1 North America Coagulation Market, by Country
12.1.7.2 US
12.1.7.2.1 Overview
12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.2.3 US Coagulation Market, by Disease Indication
12.1.7.2.4 US Coagulation Market, by Type
12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.2.5 US Coagulation Market, by Offering
12.1.7.2.5.1 US Coagulation Market, by Diagnosis
12.1.7.2.5.2 US Coagulation Market, by Treatment
12.1.7.2.6 US Coagulation Market, by Technology
12.1.7.2.7 US Coagulation Market, by End User
12.1.7.3 Canada
12.1.7.3.1 Overview
12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.3.3 Canada Coagulation Market, by Disease Indication
12.1.7.3.4 Canada Coagulation Market, by Type
12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.3.5 Canada Coagulation Market, by Offering
12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
12.1.7.3.5.2 Canada Coagulation Market, by Treatment
12.1.7.3.6 Canada Coagulation Market, by Technology
12.1.7.3.7 Canada Coagulation Market, by End User
12.1.7.4 Mexico
12.1.7.4.1 Overview
12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
12.1.7.4.4 Mexico Coagulation Market, by Type
12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.4.5 Mexico Coagulation Market, by Offering
12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
12.1.7.4.5.2 US Coagulation Market, by Treatment
12.1.7.4.6 Mexico Coagulation Market, by Technology
12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
12.2.1 Overview
12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.3 Europe Coagulation Market, by Disease Indication
12.2.4 Europe Coagulation Market, by Type
12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.5 Europe Coagulation Market, by Offering
12.2.5.1 Europe Coagulation Market, by Diagnosis
12.2.5.2 Europe Coagulation Market, by Treatment
12.2.6 Europe Coagulation Market, by Technology
12.2.7 Europe Coagulation Market, by End User
12.2.8 Europe Coagulation Market by Country
12.2.8.1 Germany
12.2.8.1.1 Overview
12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.1.3 Germany Coagulation Market, by Disease Indication
12.2.8.1.4 Germany Coagulation Market, by Type
12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.1.5 Germany Coagulation Market, by Offering
12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
12.2.8.1.5.2 Germany Coagulation Market, by Treatment
12.2.8.1.6 Germany Coagulation Market, by Technology
12.2.8.1.7 Germany Coagulation Market, by End User
12.2.8.2 UK
12.2.8.2.1 Overview
12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.2.2 UK Coagulation Market, by Disease Indication
12.2.8.2.3 UK Coagulation Market, by Type
12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.2.4 UK Coagulation Market, by Offering
12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
12.2.8.2.4.2 UK Coagulation Market, by Treatment
12.2.8.2.5 UK Coagulation Market, by Technology
12.2.8.2.6 UK Coagulation Market, by End User
12.2.8.3 France
12.2.8.3.1 Overview
12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.3.2 France Coagulation Market, by Disease Indication
12.2.8.3.3 France Coagulation Market, by Type
12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.3.4 France Coagulation Market, by Offering
12.2.8.3.4.1 France Coagulation Market, by Diagnosis
12.2.8.3.4.2 France Coagulation Market, by Treatment
12.2.8.3.5 France Coagulation Market, by Technology
12.2.8.3.6 France Coagulation Market, by End User
12.2.8.4 Italy
12.2.8.4.1 Overview
12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.4.2 Italy Coagulation Market, by Disease Indication
12.2.8.4.3 Italy Coagulation Market, by Type
12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.4.4 Italy Coagulation Market, by Offering
12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
12.2.8.4.4.2 Italy Coagulation Market, by Treatment
12.2.8.4.5 Italy Coagulation Market, by Technology
12.2.8.4.6 Italy Coagulation Market, by End User
12.2.8.5 Spain
12.2.8.5.1 Overview
12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.5.3 Spain Coagulation Market, by Disease Indication
12.2.8.5.4 Spain Coagulation Market, by Type
12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.5.5 Spain Coagulation Market, by Offering
12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
12.2.8.5.5.2 Spain Coagulation Market, by Treatment
12.2.8.5.6 Spain Coagulation Market, by Technology
12.2.8.5.7 Spain Coagulation Market, by End User
12.2.8.6 Rest of Europe
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
12.2.8.6.4 Rest of Europe Coagulation Market, by Type
12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
12.3.1 Overview
12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.3 Asia Pacific Coagulation Market, by Disease Indication
12.3.4 Asia Pacific Coagulation Market, by Type
12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.5 Asia Pacific Coagulation Market, by Offering
12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
12.3.5.2 Asia Pacific Coagulation Market, by Treatment
12.3.6 Asia Pacific Coagulation Market, by Technology
12.3.7 Asia Pacific Coagulation Market, by End User
12.3.8 Asia Pacific Coagulation Market by Country
12.3.8.1 China
12.3.8.1.1 Overview
12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.1.3 China Coagulation Market, by Disease Indication
12.3.8.1.4 China Coagulation Market, by Type
12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.1.5 China Coagulation Market, by Offering
12.3.8.1.5.1 China Coagulation Market, by Diagnosis
12.3.8.1.5.2 China Coagulation Market, by Treatment
12.3.8.1.6 China Coagulation Market, by Technology
12.3.8.1.7 China Coagulation Market, by End User
12.3.8.2 Japan
12.3.8.2.1 Overview
12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.2.3 Japan Coagulation Market, by Disease Indication
12.3.8.2.4 Japan Coagulation Market, by Type
12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.2.5 Japan Coagulation Market, by Offering
12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
12.3.8.2.5.2 Japan Coagulation Market, by Treatment
12.3.8.2.6 Japan Coagulation Market, by Technology
12.3.8.2.7 Japan Coagulation Market, by End User
12.3.8.3 India
12.3.8.3.1 Overview
12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.3.3 India Coagulation Market, by Disease Indication
12.3.8.3.4 India Coagulation Market, by Type
12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.3.5 India Coagulation Market, by Offering
12.3.8.3.5.1 India Coagulation Market, by Diagnosis
12.3.8.3.5.2 India Coagulation Market, by Treatment
12.3.8.3.6 India Coagulation Market, by Technology
12.3.8.3.7 India Coagulation Market, by End User
12.3.8.4 Australia
12.3.8.4.1 Overview
12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.4.3 Australia Coagulation Market, by Disease Indication
12.3.8.4.4 Australia Coagulation Market, by Type
12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.4.5 Australia Coagulation Market, by Offering
12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
12.3.8.4.5.2 Australia Coagulation Market, by Treatment
12.3.8.4.6 Australia Coagulation Market, by Technology
12.3.8.4.7 Australia Coagulation Market, by End User
12.3.8.5 South Korea
12.3.8.5.1 Overview
12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
12.3.8.5.4 South Korea Coagulation Market, by Type
12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.5.5 South Korea Coagulation Market, by Offering
12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
12.3.8.5.6 South Korea Coagulation Market, by Technology
12.3.8.5.7 South Korea Coagulation Market, by End User
12.3.8.6 Rest of Asia Pacific
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
12.4.1 Overview
12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
12.4.4 Middle East & Africa Coagulation Market, by Type
12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.5 Middle East & Africa Coagulation Market, by Offering
12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
12.4.6 Middle East & Africa Coagulation Market, by Technology
12.4.7 Middle East & Africa Coagulation Market, by End User
12.4.7.1 Middle East & Africa Coagulation Market by Country
12.4.7.2 Saudi Arabia
12.4.7.2.1 Overview
12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
12.4.7.3 South Africa
12.4.7.3.1 Overview
12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
12.4.7.3.4 South Africa Coagulation Market, by Type
12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.3.5 South Africa Coagulation Market, by Offering
12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
12.4.7.3.6 South Africa Coagulation Market, by Technology
12.4.7.3.7 South Africa Coagulation Market, by End User
12.4.7.4 UAE
12.4.7.4.1 Overview
12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.4.3 UAE Coagulation Market, by Disease Indication
12.4.7.4.4 UAE Coagulation Market, by Type
12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.4.5 UAE Coagulation Market, by Offering
12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
12.4.7.4.5.2 UAE Coagulation Market, by Treatment
12.4.7.4.6 UAE Coagulation Market, by Technology
12.4.7.4.7 UAE Coagulation Market, by End User
12.4.7.5 Rest of Middle East & Africa
12.4.7.5.1 Overview
12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
12.5.1 Overview
12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.3 South & Central America Coagulation Market, by Disease Indication
12.5.4 South & Central America Coagulation Market, by Type
12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.5 South & Central America Coagulation Market, by Offering
12.5.5.1 South & Central America Coagulation Market, by Diagnosis
12.5.5.2 South & Central America Coagulation Market, by Treatment
12.5.6 South & Central America Coagulation Market, by Technology
12.5.7 South & Central America Coagulation Market, by End User
12.5.8 South & Central America Coagulation Market by Country
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
12.5.8.1.4 Brazil Coagulation Market, by Type
12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.1.5 Brazil Coagulation Market, by Offering
12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
12.5.8.1.6 Brazil Coagulation Market, by Technology
12.5.8.1.7 Brazil Coagulation Market, by End User
12.5.8.2 Argentina
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
12.5.8.2.4 Argentina Coagulation Market, by Type
12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.2.5 Argentina Coagulation Market, by Offering
12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
12.5.8.2.6 Argentina Coagulation Market, by Technology
12.5.8.2.7 Argentina Coagulation Market, by End User
12.5.8.3 Rest of South & Central America
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User
13. COAGULATION MARKET–INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. COMPANY PROFILES
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
14.2.1 Key Facts
14.2.
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. COAGULATION MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. COAGULATION MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Market Drivers
5.1.2 Increasing Prevalence of Blood Disorders
5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. COAGULATION MARKET - GLOBAL MARKET ANALYSIS
6.1 Coagulation Market Revenue (US$ million), 2022 – 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030
7. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE INDICATION
7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
7.3.1 Overview
7.3.2 Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
7.4.1 Overview
7.4.2 Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
7.5.1 Overview
7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
7.6.1 Overview
7.6.2 Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
7.7.1 Overview
7.7.2 Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand's Disease
7.8.1 Overview
7.8.2 Von Willebrand's Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY TYPE
8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
8.3.1 Overview
8.3.2 Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
8.4.1 Overview
8.4.2 Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY OFFERING
9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
9.3.1 Overview
9.3.2 Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
9.4.1 Overview
9.4.2 Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Global Coagulation Market, by Treatment
10. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
10.3.1 Overview
10.3.2 Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
10.4.1 Overview
10.4.2 Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
10.5.1 Overview
10.5.2 Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. GLOBAL COAGULATION MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
11.3.1 Overview
11.3.2 Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
12. COAGULATION MARKET - GEOGRAPHICAL ANALYSIS
12.1 North America Coagulation Market, Revenue And Forecast To 2030
12.1.1 Overview
12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.3 North America Coagulation Market, by Disease Indication
12.1.4 North America Coagulation Market, by Type
12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
12.1.5 North America Coagulation Market, by Offering
12.1.5.1 North America Coagulation Market, by Diagnosis
12.1.5.2 North America Coagulation Market, by Treatment
12.1.6 North America Coagulation Market, by Technology
12.1.7 North America Coagulation Market, by End User
12.1.7.1 North America Coagulation Market, by Country
12.1.7.2 US
12.1.7.2.1 Overview
12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.2.3 US Coagulation Market, by Disease Indication
12.1.7.2.4 US Coagulation Market, by Type
12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.2.5 US Coagulation Market, by Offering
12.1.7.2.5.1 US Coagulation Market, by Diagnosis
12.1.7.2.5.2 US Coagulation Market, by Treatment
12.1.7.2.6 US Coagulation Market, by Technology
12.1.7.2.7 US Coagulation Market, by End User
12.1.7.3 Canada
12.1.7.3.1 Overview
12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.3.3 Canada Coagulation Market, by Disease Indication
12.1.7.3.4 Canada Coagulation Market, by Type
12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.3.5 Canada Coagulation Market, by Offering
12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
12.1.7.3.5.2 Canada Coagulation Market, by Treatment
12.1.7.3.6 Canada Coagulation Market, by Technology
12.1.7.3.7 Canada Coagulation Market, by End User
12.1.7.4 Mexico
12.1.7.4.1 Overview
12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
12.1.7.4.4 Mexico Coagulation Market, by Type
12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.4.5 Mexico Coagulation Market, by Offering
12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
12.1.7.4.5.2 US Coagulation Market, by Treatment
12.1.7.4.6 Mexico Coagulation Market, by Technology
12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
12.2.1 Overview
12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.3 Europe Coagulation Market, by Disease Indication
12.2.4 Europe Coagulation Market, by Type
12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.5 Europe Coagulation Market, by Offering
12.2.5.1 Europe Coagulation Market, by Diagnosis
12.2.5.2 Europe Coagulation Market, by Treatment
12.2.6 Europe Coagulation Market, by Technology
12.2.7 Europe Coagulation Market, by End User
12.2.8 Europe Coagulation Market by Country
12.2.8.1 Germany
12.2.8.1.1 Overview
12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.1.3 Germany Coagulation Market, by Disease Indication
12.2.8.1.4 Germany Coagulation Market, by Type
12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.1.5 Germany Coagulation Market, by Offering
12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
12.2.8.1.5.2 Germany Coagulation Market, by Treatment
12.2.8.1.6 Germany Coagulation Market, by Technology
12.2.8.1.7 Germany Coagulation Market, by End User
12.2.8.2 UK
12.2.8.2.1 Overview
12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.2.2 UK Coagulation Market, by Disease Indication
12.2.8.2.3 UK Coagulation Market, by Type
12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.2.4 UK Coagulation Market, by Offering
12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
12.2.8.2.4.2 UK Coagulation Market, by Treatment
12.2.8.2.5 UK Coagulation Market, by Technology
12.2.8.2.6 UK Coagulation Market, by End User
12.2.8.3 France
12.2.8.3.1 Overview
12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.3.2 France Coagulation Market, by Disease Indication
12.2.8.3.3 France Coagulation Market, by Type
12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.3.4 France Coagulation Market, by Offering
12.2.8.3.4.1 France Coagulation Market, by Diagnosis
12.2.8.3.4.2 France Coagulation Market, by Treatment
12.2.8.3.5 France Coagulation Market, by Technology
12.2.8.3.6 France Coagulation Market, by End User
12.2.8.4 Italy
12.2.8.4.1 Overview
12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.4.2 Italy Coagulation Market, by Disease Indication
12.2.8.4.3 Italy Coagulation Market, by Type
12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.4.4 Italy Coagulation Market, by Offering
12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
12.2.8.4.4.2 Italy Coagulation Market, by Treatment
12.2.8.4.5 Italy Coagulation Market, by Technology
12.2.8.4.6 Italy Coagulation Market, by End User
12.2.8.5 Spain
12.2.8.5.1 Overview
12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.5.3 Spain Coagulation Market, by Disease Indication
12.2.8.5.4 Spain Coagulation Market, by Type
12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.5.5 Spain Coagulation Market, by Offering
12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
12.2.8.5.5.2 Spain Coagulation Market, by Treatment
12.2.8.5.6 Spain Coagulation Market, by Technology
12.2.8.5.7 Spain Coagulation Market, by End User
12.2.8.6 Rest of Europe
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
12.2.8.6.4 Rest of Europe Coagulation Market, by Type
12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
12.3.1 Overview
12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.3 Asia Pacific Coagulation Market, by Disease Indication
12.3.4 Asia Pacific Coagulation Market, by Type
12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.5 Asia Pacific Coagulation Market, by Offering
12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
12.3.5.2 Asia Pacific Coagulation Market, by Treatment
12.3.6 Asia Pacific Coagulation Market, by Technology
12.3.7 Asia Pacific Coagulation Market, by End User
12.3.8 Asia Pacific Coagulation Market by Country
12.3.8.1 China
12.3.8.1.1 Overview
12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.1.3 China Coagulation Market, by Disease Indication
12.3.8.1.4 China Coagulation Market, by Type
12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.1.5 China Coagulation Market, by Offering
12.3.8.1.5.1 China Coagulation Market, by Diagnosis
12.3.8.1.5.2 China Coagulation Market, by Treatment
12.3.8.1.6 China Coagulation Market, by Technology
12.3.8.1.7 China Coagulation Market, by End User
12.3.8.2 Japan
12.3.8.2.1 Overview
12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.2.3 Japan Coagulation Market, by Disease Indication
12.3.8.2.4 Japan Coagulation Market, by Type
12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.2.5 Japan Coagulation Market, by Offering
12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
12.3.8.2.5.2 Japan Coagulation Market, by Treatment
12.3.8.2.6 Japan Coagulation Market, by Technology
12.3.8.2.7 Japan Coagulation Market, by End User
12.3.8.3 India
12.3.8.3.1 Overview
12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.3.3 India Coagulation Market, by Disease Indication
12.3.8.3.4 India Coagulation Market, by Type
12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.3.5 India Coagulation Market, by Offering
12.3.8.3.5.1 India Coagulation Market, by Diagnosis
12.3.8.3.5.2 India Coagulation Market, by Treatment
12.3.8.3.6 India Coagulation Market, by Technology
12.3.8.3.7 India Coagulation Market, by End User
12.3.8.4 Australia
12.3.8.4.1 Overview
12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.4.3 Australia Coagulation Market, by Disease Indication
12.3.8.4.4 Australia Coagulation Market, by Type
12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.4.5 Australia Coagulation Market, by Offering
12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
12.3.8.4.5.2 Australia Coagulation Market, by Treatment
12.3.8.4.6 Australia Coagulation Market, by Technology
12.3.8.4.7 Australia Coagulation Market, by End User
12.3.8.5 South Korea
12.3.8.5.1 Overview
12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
12.3.8.5.4 South Korea Coagulation Market, by Type
12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.5.5 South Korea Coagulation Market, by Offering
12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
12.3.8.5.6 South Korea Coagulation Market, by Technology
12.3.8.5.7 South Korea Coagulation Market, by End User
12.3.8.6 Rest of Asia Pacific
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
12.4.1 Overview
12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
12.4.4 Middle East & Africa Coagulation Market, by Type
12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.5 Middle East & Africa Coagulation Market, by Offering
12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
12.4.6 Middle East & Africa Coagulation Market, by Technology
12.4.7 Middle East & Africa Coagulation Market, by End User
12.4.7.1 Middle East & Africa Coagulation Market by Country
12.4.7.2 Saudi Arabia
12.4.7.2.1 Overview
12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
12.4.7.3 South Africa
12.4.7.3.1 Overview
12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
12.4.7.3.4 South Africa Coagulation Market, by Type
12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.3.5 South Africa Coagulation Market, by Offering
12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
12.4.7.3.6 South Africa Coagulation Market, by Technology
12.4.7.3.7 South Africa Coagulation Market, by End User
12.4.7.4 UAE
12.4.7.4.1 Overview
12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.4.3 UAE Coagulation Market, by Disease Indication
12.4.7.4.4 UAE Coagulation Market, by Type
12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.4.5 UAE Coagulation Market, by Offering
12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
12.4.7.4.5.2 UAE Coagulation Market, by Treatment
12.4.7.4.6 UAE Coagulation Market, by Technology
12.4.7.4.7 UAE Coagulation Market, by End User
12.4.7.5 Rest of Middle East & Africa
12.4.7.5.1 Overview
12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
12.5.1 Overview
12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.3 South & Central America Coagulation Market, by Disease Indication
12.5.4 South & Central America Coagulation Market, by Type
12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.5 South & Central America Coagulation Market, by Offering
12.5.5.1 South & Central America Coagulation Market, by Diagnosis
12.5.5.2 South & Central America Coagulation Market, by Treatment
12.5.6 South & Central America Coagulation Market, by Technology
12.5.7 South & Central America Coagulation Market, by End User
12.5.8 South & Central America Coagulation Market by Country
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
12.5.8.1.4 Brazil Coagulation Market, by Type
12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.1.5 Brazil Coagulation Market, by Offering
12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
12.5.8.1.6 Brazil Coagulation Market, by Technology
12.5.8.1.7 Brazil Coagulation Market, by End User
12.5.8.2 Argentina
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
12.5.8.2.4 Argentina Coagulation Market, by Type
12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.2.5 Argentina Coagulation Market, by Offering
12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
12.5.8.2.6 Argentina Coagulation Market, by Technology
12.5.8.2.7 Argentina Coagulation Market, by End User
12.5.8.3 Rest of South & Central America
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User
13. COAGULATION MARKET–INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. COMPANY PROFILES
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
14.2.1 Key Facts
14.2.
